Gary L. Pattee

3.2k total citations
58 papers, 1.7k citations indexed

About

Gary L. Pattee is a scholar working on Neurology, Speech and Hearing and Genetics. According to data from OpenAlex, Gary L. Pattee has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 16 papers in Speech and Hearing and 15 papers in Genetics. Recurrent topics in Gary L. Pattee's work include Amyotrophic Lateral Sclerosis Research (35 papers), Dysphagia Assessment and Management (16 papers) and Neurogenetic and Muscular Disorders Research (15 papers). Gary L. Pattee is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (35 papers), Dysphagia Assessment and Management (16 papers) and Neurogenetic and Muscular Disorders Research (15 papers). Gary L. Pattee collaborates with scholars based in United States, Canada and United Kingdom. Gary L. Pattee's co-authors include Laura J. Ball, David R. Beukelman, Jordan R. Green, Lorne Zinman, Yana Yunusova, James D. Berry, Antje S. Mefferd, James Wymer, Jun Wang and Amy D. Willis and has published in prestigious journals such as PLoS ONE, Neurology and Experimental Neurology.

In The Last Decade

Gary L. Pattee

56 papers receiving 1.6k citations

Peers

Countries citing papers authored by Gary L. Pattee

Since Specialization

Citations

This map shows the geographic impact of Gary L. Pattee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Pattee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Pattee more than expected).

Fields of papers citing papers by Gary L. Pattee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Pattee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Pattee. The network helps show where Gary L. Pattee may publish in the future.

Co-authorship network of co-authors of Gary L. Pattee

This figure shows the co-authorship network connecting the top 25 collaborators of Gary L. Pattee. A scholar is included among the top collaborators of Gary L. Pattee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary L. Pattee. Gary L. Pattee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of human superoxide dismutase (SOD) 1 G93A and chlorovirus ATCV-1 SOD increases the response of macrophages to inflammatory stimulants, including ATCV-1 major capsid protein glycans 2025 ·Immunobiology ·Thomas M. Petro, Ahmed Esmael, Gary L. Pattee, (unknown), Fabrizio Chiodo, Irina Agarkova, David D. Dunigan, James L. Van Etten	1
2	Carbohydrate-mediated interactions between chloroviruses and the immune system 2024 ·Communications Biology ·Immacolata Speciale, Anna Notaro, Sven C. M. Bruijns, Yvette van Kooyk, Ahmed Esmael, Antonio Molinaro, (unknown), Ernesto Rodríguez, Thomas M. Petro, Irina V. Agarkova, Gary L. Pattee, James L. Van Etten, Cristina De Castro, Fabrizio Chiodo	2
3	Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis 2023 ·Expert Review of Neurotherapeutics ·Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, (unknown), Sally Nelson	15
4	ALSUntangled #66: antimycobacterial antibiotics. 2022 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ellen S. Pierce, Paul E. Barkhaus, (unknown), Mark B. Bromberg, Gregory T. Carter, (unknown), David Greeley, (unknown), (unknown), Isaac Lund, Christopher McDermott, Gary L. Pattee, (unknown), Meraida Polak, (unknown), Paul Wicks, Richard Bedlack	1
5	Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study 2022 ·BMJ Open ·Yana Yunusova, Ashley A. Waito, Carolina Barnett, (unknown), Rosemary Martino, Agessandro Abrahão, Gary L. Pattee, James D. Berry, Lorne Zinman, Jordan R. Green	2
6	24-Week Results From Phase 3 Study MT-1186-A01 an Open-Label, Multicenter Safety Study of Oral Edaravone in Subjects With Amyotrophic Lateral Sclerosis (P1-13.001) 2022 ·Neurology ·Angela Genge, Gary L. Pattee, Gen Sobue, Philippe Couratier, (unknown), Manabu Hirai, Takeshi Sakata, (unknown), (unknown)	1
7	Chlorovirus ATCV-1 Accelerates Motor Deterioration in SOD1-G93A Transgenic Mice and Its SOD1 Augments Induction of Inflammatory Factors From Murine Macrophages 2022 ·Frontiers in Neurology ·Thomas M. Petro, Irina Agarkova, Ahmed Esmael, David D. Dunigan, James L. Van Etten, Gary L. Pattee	4
8	A multidimensional facial surface EMG analysis for objective assessment of bulbar involvement in amyotrophic lateral sclerosis 2021 ·Clinical Neurophysiology ·Panying Rong, Gary L. Pattee	6
9	Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self‐report scale (Center for Neurologic Study Bulbar Function Scale) 2018 ·European Journal of Neurology ·Richard Smith, Eric A. Macklin, Kathleen Myers, Gary L. Pattee, Kimberly Goslin, Gregg Meekins, (unknown), Jeremy M. Shefner, Erik P. Pioro	31
10	Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial 2017 ·Neurotherapeutics ·Richard Smith, Erik P. Pioro, Kathleen Myers, Michael Sirdofsky, Kimberly Goslin, Gregg Meekins, Hong Yu, James Wymer, Merit Cudkowicz, Eric A. Macklin, David Schoenfeld, Gary L. Pattee	76
11	Speaking rate effects on articulatory pattern consistency in talkers with mild ALS 2014 ·Clinical Linguistics & Phonetics ·Antje S. Mefferd, Gary L. Pattee, Jordan R. Green	46
12	Peer recommendations on how to improve clinical research, and Conference wrap-up 2013 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·David A. Chad, Lewis P. Rowland, Carmel Armon, Richard Bedlack, Heather D. Durham, Pam Factor‐Litvak, Terry Heiman‐Patterson, Daragh Heitzman, David Lacomis, Albert C. Ludolph, Nicholas J. Maragakis, Robert G. Miller, Gary L. Pattee, Christen Shoesmith, Eric J. Sorenson, Martin R. Turner	1
13	Bulbar and speech motor assessment in ALS: Challenges and future directions 2013 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Jordan R. Green, Yana Yunusova, Mili Kuruvilla-Dugdale, Jun Wang, Gary L. Pattee, Lori Synhorst, Lorne Zinman, James D. Berry	161
14	Tongue Movements and Their\nAcoustic Consequences in Amyotrophic\nLateral Sclerosis 2012 ·Insecta mundi ·Yana Yunusova, Jordan R. Green, (unknown), Jun Wang, Gary L. Pattee, Lorne Zinman	80
15	A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS) 2011 ·Journal of Visualized Experiments ·Yana Yunusova, Jordan R. Green, Jun Wang, Gary L. Pattee, Lorne Zinman	30
16	Late AAC Assessment for Individuals with Amyotrophic Lateral Sclerosis 2010 ·(unknown), Laura J. Ball, Susan Fager, David R. Beukelman, Gary L. Pattee	14
17	R(+) pramipexole as a mitochondrially focused neuroprotectant: Initial early phase studies in ALS 2008 ·Amyotrophic Lateral Sclerosis ·Hua Wang, (unknown), (unknown), (unknown), Ted M. Burns, (unknown), David Lacomis, Gary L. Pattee, Lawrence H. Phillips, Nina J. Solenski, Saša Živković, James P. Bennett	37
18	Communication effectiveness of individuals with amyotrophic lateral sclerosis 2003 ·Journal of Communication Disorders ·Laura J. Ball, David R. Beukelman, Gary L. Pattee	81
19	Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment 2003 ·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders ·Gary L. Pattee, (unknown), (unknown), James P. Bennett	32
20	A protocol for identification of early bulbar signs in amyotrophic lateral sclerosis 2001 ·Journal of the Neurological Sciences ·Laura J. Ball, Amy D. Willis, David R. Beukelman, Gary L. Pattee	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact